Search

everythinglearnresearchcommunity

for

Search:↓

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Finasteride treats hair loss and reduces prostate cancer risk.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

ERG increases SOX9, promoting prostate cancer growth and invasion.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.

Gene variation affects prostate issues and hair loss.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Endocrine therapies for cancer significantly increase the risk of hair loss.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Nanoemulsions can effectively treat skin cancer with fewer side effects.